Optimal Medical Therapy Versus Septal Reduction Therapy: Progress, Limitations, and Need for RCT

JACC Adv. 2024 Dec 9;4(1):101412. doi: 10.1016/j.jacadv.2024.101412. eCollection 2025 Jan.

Authors

Francis Joshua Beloy¹, Jillian Reeze Medina², Ralf Martz Sulague³, Jacques Kpodonu⁴

Affiliations

¹ Montefiore St. Luke's Cornwall, Newburgh, New York, USA.
² College of Medicine, Manila Central University, Caloocan, Metro Manila, Philippines.
³ Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
⁴ Division of Cardiac Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

No abstract available

Keywords: heart failure; hypertrophic cardiomyopathy; optimal medical therapy; septal reduction therapy.

Publication types

Editorial